Meng‐Xin Tian

1.9k citations
35 papers · 913 indexed · h-index 20
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers)Hepatocellular Carcinoma Treatment and Prognosis (10 papers)Pancreatic and Hepatic Oncology Research (6 papers)
Partner nations
ChinaEthiopiaIndia

In The Last Decade

Meng‐Xin Tian

34 papers receiving 905 citations

Peers

Meng‐Xin Tian
Comparison fields: 5 of 84
  • Molecular Biology 343
  • Oncology 327
  • Cancer Research 254
  • Surgery 224
  • Pulmonary and Respiratory Medicine 178
Replace Maarten W. Nijkamp with:
Maarten W. Nijkamp Netherlands
Liu‐Xiao Yang China
Zizhen Feng China
Shanzhou� Huang China
Jeroen Dekervel Belgium
Xi‐Fei Jiang China
Itzhak Avital United States
Tatsuhiko Kakisaka Japan
Jiaqiang Ma China
Henry Xiong United States
Meng‐Xin Tian relative to Maarten W. Nijkamp Netherlands Maarten W. Nijkamp's profile →
Citations per field
00.5×1.5×2.1×
Maarten W. Nijkamp · 1×
Citations per year

Countries citing papers authored by Meng‐Xin Tian

Since Specialization
Citations

This map shows the geographic impact of Meng‐Xin Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Xin Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Xin Tian more than expected).

Fields of papers citing papers by Meng‐Xin Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Xin Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Xin Tian. The network helps show where Meng‐Xin Tian may publish in the future.

Co-authorship network of co-authors of Meng‐Xin Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Xin Tian. A scholar is included among the top collaborators of Meng‐Xin Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Xin Tian. Meng‐Xin Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 23
2 0
3 28
4 19
5 19
6 28
7 5
8 11
9 70
10 14
11 35
12 12
13 28
14 17
15 15
16 11
17 23
18 44
19 34
20 29

About Meng‐Xin Tian

Meng‐Xin Tian is a scholar working on Hepatology, Cancer Research and Oncology, having authored 35 papers that have together received 913 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Cancer Research (254 citations), Hepatology (122 citations) and Oncology (327 citations). Meng‐Xin Tian has collaborated with scholars based in China, Ethiopia and India. Frequent co-authors include Jia Fan, Ying‐Hong Shi, Jian Zhou, Wei‐Ren Liu, Zhen‐Bin Ding, Lei Jin, Yuan‐Fei Peng, Xi‐Fei Jiang, Zhi Dai and Yongyong Shi. Their work appears in journals such as Oncogene, Nanoscale and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026